金融业


债务 更改 日
Abbott USD 34.05B 20.19B 2026-03
Acadia Pharmaceuticals USD 73.85M 23.06M 2026-06
Agios Pharmaceuticals USD 31.17M 4.57M 2026-06
Akebia Therapeutics USD 46.51M 7.82M 2025-03
Alnylam Pharmaceuticals USD 2.48B 1.21B 2026-09
AstraZeneca USD 32.24B 1.68B 2026-06
BioMarin Pharmaceutical USD 4.19B 11.99M 2026-09
Coherus Biosciences USD 294.92M 1.25M 2025-03
Eli Lilly USD 54.91B 11.54B 2026-06
Halozyme Therapeutics USD 2.15B 2.02M 2026-06
Illumina USD 2.54B 9M 2026-03
Insmed USD 544.86M 180.93M 2026-09
Ironwood Pharmaceuticals USD 583.99M 14.83M 2024-12
J&J USD 49.04B 5.95B 2026-06
Lexicon Pharmaceuticals USD 99.51M 243K 2023-12
MacroGenics USD 35.09M 1.42M 2026-06
MannKind USD 330.85M 112K 2026-06
Merck USD 53.91B 4.79B 2026-06
Moderna USD 1.29B 11M 2026-06
Novartis USD 49.01B 2.02B 2026-06
PTC Therapeutics USD 2.84B 2.15B 2026-09
Puma Biotechnology USD 89.06M 55.07M 2024-06
Sarepta Therapeutics USD 857.36M 188.48M 2026-09
Thermo Fisher Scientific USD 42.55B 612M 2026-06
Ultragenyx Pharmaceutical USD 36M 2.17M 2025-12
United Therapeutics USD 200M 100M 2025-03
Vanda Pharmaceuticals USD 4.96M 4.96M 2024-12